https://www.selleckchem.com/pr....oducts/peficitinb-as
Taken together, the results from the present provided novel insights into the roles of KTN1‑AS1 in GBM, and suggested that the KTN1‑AS1/miR‑505‑3p axis may be considered as a novel therapeutic target for the treatment of patients with GBM.Plant-derived proteases, bromelain, papain, and ficin are broad-acting enzymes with generally recognized as safe (GRAS) status for foods and have current application in several food industries. These proteases have also been reported to have antimicrobial properties. This study
Like
Comment
Share
